A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8+ T cells

Cancer Res. 2003 Jul 15;63(14):4095-100.

Abstract

It is thought that tumor rejection by CD8(+) T-cell effectors is primarily mediated by direct killing. We show that rejection of different tumors (fibrosarcoma, ras-transformed fibroblasts, colon carcinoma, and plasmacytoma) by CD8(+) T cells is always preceded by inhibition of tumor-induced angiogenesis. Angiostasis and tumor rejection were observed in perforin but not in IFN-gamma-deficient mice. Furthermore, adoptive transfer of tumor-specific CD8(+) T cells from IFN-gamma-competent mice inhibited angiogenesis of lung metastases in comparison to those from IFN-gamma gene-deficient mice. Taken together with our previous findings, we conclude that IFN-gamma-dependent antiangiogenesis is a general mechanism involved in tumor rejection by CD4(+) and CD8(+) T-cell effectors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3 Cells
  • Animals
  • CD8-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / metabolism
  • Fibrosarcoma / blood supply
  • Fibrosarcoma / immunology
  • Fibrosarcoma / therapy
  • Immunization
  • Immunotherapy, Adoptive / methods*
  • Interferon-gamma / biosynthesis
  • Interferon-gamma / immunology*
  • Melanoma, Experimental / blood supply
  • Melanoma, Experimental / immunology
  • Melanoma, Experimental / therapy
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • Neoplasms, Experimental / blood supply
  • Neoplasms, Experimental / immunology*
  • Neoplasms, Experimental / therapy
  • Neovascularization, Pathologic / immunology*
  • Neovascularization, Pathologic / prevention & control

Substances

  • Interferon-gamma